Table 2.
Hazard ratios for incident microvascular complications for patients with Lp(a) concentrations ≥30 mg/dl <30 mg/dl (reference group)
| Model 1, HR (95% CI) | p value | Model 2, HR (95% CI) | p value | |
|---|---|---|---|---|
| Retinopathy (n = 183) | ||||
| ≥30 mg/dl | 0.94 (0.69, 1.26) | 0.66 | 1.02 (0.73, 1.43) | 0.90 |
| Nephropathy (n = 185) | ||||
| ≥30 mg/dl | 1.04 (0.78, 1.38) | 0.81 | 1.03 (0.73, 1.44) | 0.88 |
| Neuropathy (n = 202) | ||||
| ≥30 mg/dl | 0.99 (0.74, 1.33) | 0.95 | 0.99 (0.70, 1.39) | 0.94 |
n, numbers of patients who developed the complication
Model 1: adjusted for sex and age
Model 2: additionally adjusted for MAP, non-HDL-cholesterol, HDL-cholesterol, BMI, duration of type 2 diabetes, HbA1c and smoking (never/former/current)